Ensuring a Robust DNA Analysis and the Best Clinical Interpretation by Generating a High-Quality Data Set

OncoDEEP® Kit enables laboratories to achieve and consistently replicate high-quality sequencing data regarding coverage and sensitivity. Based on analytical performance this Whitepaper assesses the precision of OncoDEEP® Kit while measuring the repeatability and reproducibility.

Combined with a solid BioIT pipeline and clinical interpretation software tools, robust molecular tumor profi ling data enable your lab to successfully identify a broader range of treatment options for patients, all while saving on the costs and burdens associated with outsourcing. By leveraging this innovative technology, labs can streamline the sequencing process, thereby increasing their efficiency as never seen before.

This field is for validation purposes and should be left unchanged.

You may also be interested in these resources

Scientific Application Note

HEPATOCELLULAR CANCER Combination PD-L1 and VEGFR inhibition (atezolizumab plus bevacizumab) delivered better overall and progression-free survival than standard of care sorafenib in a pivotal phase 3 study.

ATEZOLIZUMAB PLUS BEVACIZUMAB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA Richard S. Finn et al N Engl J Med 2020; 382:1894-1905 BACKGROUND The combination of atezolizumab and bevacizumab showed encouraging antitumor activity and safety in a phase 1b...

Share This